A human liver chimeric mouse model for non-alcoholic fatty liver disease
Authors:
Open Access
- 1 June 2021
- journal article
- research article
- Published by Elsevier in JHEP Reports
- Vol. 3 (3) , 100281
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- National Heart Lung and Blood Institute
- American Heart Association Inc
- National Institute of Diabetes and Digestive and Kidney Diseases
This publication has 50 references indexed in Scilit:
- Differential Intrahepatic Phospholipid Zonation in Simple Steatosis and Nonalcoholic SteatohepatitisPLOS ONE, 2013
- Time-Restricted Feeding without Reducing Caloric Intake Prevents Metabolic Diseases in Mice Fed a High-Fat DietCell Metabolism, 2012
- Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver DiseaseCell Metabolism, 2012
- Increased Diacylglycerols Characterize Hepatic Lipid Changes in Progression of Human Nonalcoholic Fatty Liver Disease; Comparison to a Murine ModelPLOS ONE, 2011
- Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatmentJournal of Clinical Investigation, 2010
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseaseNature Genetics, 2008
- Repopulation of adult and neonatal mice with human hepatocytes: A chimeric animal modelProceedings of the National Academy of Sciences, 2007
- Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− miceNature Biotechnology, 2007
- A lipidomic analysis of nonalcoholic fatty liver diseaseHepatology, 2007
- Hepatic Steatosis Is a Risk Factor for Postoperative Complications After Major HepatectomyAnnals of Surgery, 2007